1. Home
  2. NEO vs EEX Comparison

NEO vs EEX Comparison

Compare NEO & EEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$8.13

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Emerald Holding Inc.

EEX

Emerald Holding Inc.

HOLD

Current Price

$4.61

Market Cap

884.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEO
EEX
Founded
2001
2013
Country
United States
United States
Employees
N/A
697
Industry
Precision Instruments
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
884.2M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
NEO
EEX
Price
$8.13
$4.61
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$11.14
$7.70
AVG Volume (30 Days)
1.3M
22.4K
Earning Date
04-28-2026
04-30-2026
Dividend Yield
N/A
1.32%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.63
$7.49
Revenue Next Year
$9.73
$6.81
P/E Ratio
N/A
$236.96
Revenue Growth
N/A
N/A
52 Week Low
$4.72
$3.32
52 Week High
$13.74
$5.45

Technical Indicators

Market Signals
Indicator
NEO
EEX
Relative Strength Index (RSI) 44.05 55.36
Support Level $7.33 $4.56
Resistance Level $8.89 $4.68
Average True Range (ATR) 0.39 0.16
MACD 0.16 0.01
Stochastic Oscillator 67.85 46.43

Price Performance

Historical Comparison
NEO
EEX

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About EEX Emerald Holding Inc.

Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States, with operations in the United Kingdom (U.K.), France, and other markets. The company is engaged in three complementary business lines: Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division provides B2B e-commerce and digital merchandising solutions to manufacturers and retailers. Emerald's key revenue is derived from the Connections business, its only reportable segment.

Share on Social Networks: